Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs — especially those based on antibodies — more safely and efficiently.
Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases. They also used the sensors to monitor the structure of antibody molecules, including whether they contain a chain of sugars that interferes with proper function.
“This could help pharmaceutical companies figure out why certain drug formulations work better than others, and may help improve their effectiveness,” says Michael Strano, an MIT professor of chemical engineering and senior author of a recent paper describing the sensors in the journal ACS Nano.
The team also demonstrated how nanosensor arrays could be used to determine which cells in a population of genetically engineered, drug-producing cells are the most productive or desirable, Strano says.
Lead author of the paper is Nigel Reuel, a graduate student in Strano’s lab. The labs of MIT faculty members Krystyn Van Vliet, Christopher Love and Dane Wittrup also contributed, along with scientists from Novartis.
Testing drug strength
Strano and other scientists have previously shown that tiny, nanometer-sized sensors, such as carbon nanotubes, offer a powerful way to detect minute quantities of a substance. Carbon nanotubes are 50,000 times thinner than a human hair, and they can bind to proteins that recognize a specific target molecule. When the target is present, it alters the fluorescent signal produced by the nanotube in a way that scientists can detect.
Some researchers are trying to exploit large arrays of nanosensors, such as carbon nanotubes or semiconducting nanowires, each customized for a different target molecule, to detect many different targets at once. In the new study, Strano and his colleagues wanted to explore unique properties that emerge from large arrays of sensors that all detect the same thing.
The first feature they discovered, through mathematical modeling and experimentation, is that uniform arrays can measure the distribution in binding strength of complex proteins such as antibodies. Antibodies are naturally occurring molecules that play a key role in the body’s ability to recognize and defend against foreign invaders. In recent years, scientists have been developing antibodies to treat disease, particularly cancer. When those antibodies bind to proteins found on cancer cells, they stimulate the body’s own immune system to attack the tumor.
For antibody drugs to be effective, they must strongly bind their target. However, the manufacturing process, which relies on nonhuman, engineered cells, does not always generate consistent, uniformly binding batches of antibodies.
Currently, drug companies use time-consuming and expensive analytical processes to test each batch and make sure it meets the regulatory standards for effectiveness. However, the new MIT sensor could make this process much faster, allowing researchers to not only better monitor and control production, but also to fine-tune the manufacturing process to generate a more consistent product.
“You could use the technology to reject batches, but ideally you’d want to use it in your upstream process development to better define culture conditions, so then you wouldn’t produce spurious lots,” Reuel says.
Measuring weak interactions
Another useful trait of such sensors is their ability to measure very weak binding interactions, which could also help with antibody drug manufacturing.
The Latest Bing News on:
- A New Bionic Eye Could Give Robots and the Blind 20/20 Visionon May 22, 2020 at 7:00 am
The problem with this approach is that it limits the density of photosensors, and therefore the resolution of the bionic eye, because space needs to be left between sensors to allow the transformation ...
- New Compact, Optical Sensor for On-Chip Sensing Platformson May 21, 2020 at 8:07 am
At the Eindhoven University of Technology, a research team has designed a new, integrated optical sensor that offers enhanced resolution in measurements.
- 'Nanometrology lab on a chip' within reach thanks to new compact, optical sensoron May 20, 2020 at 6:31 am
Such sensors could play a pivotal role in accurate displacement and force measurements at the nanoscale, which is crucial for microchip and nanodevice design and evaluation. This research has been ...
- New integrated device for nanometer-scale sensingon May 20, 2020 at 6:24 am
Researchers at Eindhoven University of Technology have developed a new, integrated optical sensor that provides increased resolution in measurements and paves the way for fully integrated and compact ...
- New Bioelectronic Chemical Sensor Uses Protein Nanowires for Superior Sensitivityon May 15, 2020 at 4:01 pm
University of Massachusetts Amherst team introduces high-performing 'green' electronic sensor. Writing in the journal NanoResearch, a team at the University of Massachusetts Amherst reports this week ...
- Protein Nanowire Sensor May Have Potential Applications in Biomedicine and Healthcareon May 15, 2020 at 5:01 am
A team at the University of Massachusetts Amherst have developed the first bioelectronic ammonia sensor made from protein nanowires derived from the bacterium Geobacter. Their results provide a ...
- Making quantum 'waves' in ultrathin materialson May 14, 2020 at 11:14 am
A team of researchers has observed unusually long-lived wavelike electrons called 'plasmons' in a new class of electronically conducting material. Plasmons are very important for determining the ...
- The Most Sensitive Bioelectronic Ammonia Gas Sensor Ever Madeon May 14, 2020 at 7:51 am
A team of researchers from the University of Massachusetts Amherst has reported in the Nano Research journal that they have developed the most sensitive bioelectronic ammonia gas sensor to be ever ...
- Scientists develop high-performing ‘green’ electronic sensoron May 14, 2020 at 4:09 am
Scientists at the University of Massachusetts Amherst report that they have developed bioelectronic ammonia gas sensors that are among the most sensitive ever made. The sensor uses ...
- Researchers develop the most sensitive bioelectronic ammonia gas sensorson May 13, 2020 at 11:31 pm
Writing in the journal NanoResearch, a team at the University of Massachusetts Amherst reports this week that they have developed bioelectronic ammonia gas sensors that are among the most sensitive ...
The Latest Google Headlines on:
The Latest Bing News on:
- Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.on May 26, 2020 at 1:43 am
As the coronavirus disrupts global supply chains, lawmakers are calling on pharma to exclusively make medicines in the U.S. Pharma's pushing back.
- Sanofi Selling $13 Billion Regeneron Stake to Fund Drug Hunton May 26, 2020 at 1:39 am
Sanofi is selling a stake in Regeneron Pharmaceuticals Inc. valued at about $13 billion, giving the French drugmaker more firepower to invest in booming fields such as cancer.Regeneron has agreed to ...
- Electronic Drug Delivery Systems Market Size Worth $15.4 Billion by 2027: Grand View Research, Inc.on May 26, 2020 at 1:05 am
The global electronic drug delivery systems market size is expected to reach USD 15.4 billion by 2027 registering a CAGR of 8.9%, according ...
- Global Anti-Viral Drugs Market 2020 Growing Demands Due to COVID-19 Outbreak and its Forecast to 2026on May 25, 2020 at 11:32 pm
Viral Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly ...
- NOVASEP and LYSOGENE Announce Their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Producton May 25, 2020 at 11:09 pm
Novasep, a leading supplier of services and technologies for the life sciences industry, and Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system ...
- Canine Weight Loss Drugs Market COVID-19 Impact: Uncertainty In the Overall Global Economy Forecast Study 2020-2029on May 25, 2020 at 10:29 pm
Learn details of the Canine Weight Loss Drugs Market: Statistics, Facts And Figures, Growth Overview, Size, Major Players, Industry Outlook And Regional Analysis, Swot Analysis And Forecast To 2029.
- Pandemic Disrupts Illegal Drug Trade, Upending Both Product And Profitson May 25, 2020 at 2:00 am
The pandemic's disruption of international labor and transportation sectors has made it harder to produce and transport illegal drugs and to send profits back across national borders.
- We must bring drug manufacturing back to Americaon May 23, 2020 at 11:00 pm
Now is the time to put politics aside and come together as a nation to beat this pandemic. In the face of adversity, Americans have always stepped up to the ...
- The Trump Administration Wants To Subsidize Domestic Drug Manufacturing. The First Contract Looks Like a $350 Million Grift.on May 22, 2020 at 2:30 pm
A member of the five-month-old company's board has been touting bogus stats about America's supposed dependency on Chinese-made drugs.
- How Covid-19 is changing drug manufacturingon May 21, 2020 at 2:28 am
The contract development and manufacturing organisation has over 40 sites across the world and around 13,500 employees. Of those, Schmidt included, about 25% are working remotely due to the pandemic.